LEADER 01416nam--2200397---450 001 990000956390203316 005 20180312154804.0 010 $a3-540-42956-5 035 $a0095639 035 $aUSA010095639 035 $a(ALEPH)000095639USA01 035 $a0095639 100 $a20020212d2001----km-y0ITAy0103-------ba 101 0 $aENG 102 $aDE 200 1 $aDiscovery science$e4th International conference, DS 2001$eWashington, DC, USA, November 25-28, 2001$eproceedings$fKlaus P. Jantke ... (eds.) 210 $aBerlin [etc.]$cSpringer-Verlag$dcopyr. 2001 215 $aXII, 494 p.$cill.$d20 cm 225 $aLecture notes in artificial intelligence$v2226 300 $aSerie principale: Lecture notes in computer science 410 $12001$aLecture notes in artificial intelligence$v2226 610 1 $aElaboratori elettronici$aCongressi$a2001 610 1 $aScienze$aFilosofia$aCongressi$a2001 676 $a501.21 702 1$aJantke,$bKlaus P. 710 12$aInternational conference DS 2001 <4. ; 2001 ; Washington, USA>$0552596 801 0$aITA$bCBS$gISBD 912 $a990000956390203316 951 $a006.3 LNIA (2226)$b0027376 CBS$c006.3$d00111071 959 $aBK 969 $aSCI 979 $aALANDI$b90$c20020212$lUSA01$h1215 979 $c20020403$lUSA01$h1738 979 $aPATRY$b90$c20040406$lUSA01$h1706 996 $aDiscovery science$9973395 997 $aUNISA LEADER 01118nam0 22002771i 450 001 VAN00016892 005 20240806100306.316 010 $a88-7711-173-9 100 $a20040528d1993 |0itac50 ba 101 $aita 102 $aIT 105 $a|||| ||||| 200 1 $aVaccini, sieri, immonoglobuline$eprontuario per l'uso$fM. Pontecorvo 205 $a7. ed 210 $aTorino$cMinerva medica$d1993 215 $aXIV, 176 p.$d21 cm. 620 $dTorino$3VANL000001 676 $a615.37$cFarmaci immunologici e sieri immuni$v22 700 1$aPontecorvo$bMichele$3VANV012709$0327700 712 $aMinerva medica $3VANV108186$4650 801 $aIT$bSOL$c20240906$gRICA 899 $aBIBLIOTECA DEL DIPARTIMENTO DI SCIENZE E TECNOLOGIE AMBIENTALI BIOLOGICHE E FARMACEUTICHE$1IT-CE0101$2VAN17 912 $aVAN00016892 950 $aBIBLIOTECA DEL DIPARTIMENTO DI SCIENZE E TECNOLOGIE AMBIENTALI BIOLOGICHE E FARMACEUTICHE$d17CONS Oc24 $e17DSV266 20040528 $sBuono 996 $aVaccini, sieri, immonoglobuline$9815974 997 $aUNICAMPANIA